Clinical Development and Medical Affairs

Novartis is driven by innovation and progress, but foremost, we want to improve patient care.

Explore our medical research, clinical development, and what’s coming down the pipeline. 

Clinical Trials

Clinical Trials

Clinical Development Trials

Working closely with the care community, Novartis is currently conducting a number of clinical trials, and we are committed to finding new treatment options for cancer patients.

All compounds are either investigational or being studied for new indications. Efficacy and safety have not been established. There is no guarantee that they will become commercially available.

Clinical Development Trials 

Clinical Trial Seek Mobile App

Get cancer trial information quickly and conveniently sourced from the trusted National Institutes of Health database (https://clinicaltrials.gov). The Clinical Trial Seek app features a flexible and extensive search that makes it easy for patients and health care professionals to find, navigate, and share in-depth clinical trial information.

Web Search

ClinicalTrials.gov is a Web-based resource that provides patients, their family members, health care professionals, researchers, and the public with easy access to information on publicly and privately supported clinical studies on a wide range of diseases and conditions. The website is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH).

Clinicaltrials.gov

Novartis Medical Information

We are committed to providing the most up-to-date, accurate, and timely medical information to health care professionals.

Submit a Medical Inquiry

Real-time Medical Inquiry

(with optional video)

For additional information, please contact us at: 1-844-ONC-INFO (1-844-662-4636), Monday through Friday, 8:30 am to 5:00 pm ET.

Novartis Medical Information Mobile App

The Novartis Medical Information application provides health care professionals with accurate, succinct, and timely medical information. This app has been expanded to include General Medicines and Oncology products.

 

Independent Medical Education

Novartis Oncology discovers and develops innovative products to treat patients with cancer, and hematologic, and rare diseases. Novartis is committed to the advancement of these goals through professional education.

The Novartis Oncology Office of Grants and Education (OGE) supports independent accredited and nonaccredited medical education programs intended to provide nonpromotional, current scientific information to US health care professionals and to improve patient care. Supported programs must be compliant with all applicable legal and regulatory guidelines, and be consistent with federal laws and regulations and the ethical standards under which Novartis Pharmaceuticals Corporation (NPC) conducts business. Funding may never be linked to prescribing, purchasing, formulary status, or reimbursement activities.

For more information on the grants process or to submit an educational grant request, please visit the Novartis Grants Central Station website at http://ngcs.novartis.com/.

Oncology Grants and Education

OGE only manages grant requests for activities taking place in the United States.

Pipeline

View the depth and breadth of our research portfolio, with innovative compounds in all phases of development.

Clinical Development Trials